ADRX · Forms 3, 4, 5
Insider trades at ADARx Pharmaceuticals, Inc.
5 insiders bought $87.7M of ADARx Pharmaceuticals, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for ADARx Pharmaceuticals, Inc. (ADRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Erez Chimovits | Director | Conversion | 7,127,019 | Form 4 | |||
| Erez Chimovits | Director | Conversion | 1,333,975 | Form 4 | |||
| Erez Chimovits | Director | Conversion | 513,067 | Form 4 | |||
| Erez Chimovits | Director | Conversion | 256,448 | Form 4 | |||
| Erez Chimovits | Director | Buy | 61,516 | $17.00 | $1M | Form 4 | |
| Carl L Gordon | Director | Conversion | 10,690,530 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 2,000,962 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 769,601 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 564,187 | Form 4 | |||
| Carl L Gordon | Director | Buy | 300,249 | $17.00 | $5.1M | Form 4 | |
| Carl L Gordon | Director | Conversion | 7,127,019 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 1,333,975 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 513,067 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 256,448 | Form 4 | |||
| Carl L Gordon | Director | Buy | 61,516 | $17.00 | $1M | Form 4 | |
| Carl L Gordon | Director | Buy | 588,235 | $17.00 | $10M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 10,690,530 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 2,000,962 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 769,601 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 564,187 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 300,249 | $17.00 | $5.1M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 7,127,019 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 1,333,975 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 513,067 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 256,448 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 61,516 | $17.00 | $1M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Buy | 588,235 | $17.00 | $10M | Form 4 | |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 3,334,938 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 1,113,666 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 512,897 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Buy | 592,593 | $17.00 | $10.1M | Form 4 | |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 1,538,691 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Buy | 414,814 | $17.00 | $7.1M | Form 4 | |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 1,667,468 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Conversion | 169,001 | Form 4 | |||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Buy | 592,593 | $17.00 | $10.1M | Form 4 | |
| Simeon George | Director | Conversion | 3,334,938 | Form 4 | |||
| Simeon George | Director | Conversion | 1,113,666 | Form 4 | |||
| Simeon George | Director | Conversion | 512,897 | Form 4 | |||
| Simeon George | Director | Buy | 592,593 | $17.00 | $10.1M | Form 4 | |
| Simeon George | Director | Conversion | 1,538,691 | Form 4 | |||
| Simeon George | Director | Buy | 414,814 | $17.00 | $7.1M | Form 4 | |
| Simeon George | Director | Conversion | 1,667,468 | Form 4 | |||
| Simeon George | Director | Conversion | 169,001 | Form 4 | |||
| Simeon George | Director | Buy | 592,593 | $17.00 | $10.1M | Form 4 | |
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 8,908,775 | Form 4 | |||
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 1,667,469 | Form 4 | |||
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 513,067 | Form 4 | |||
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 153,868 | Form 4 | |||
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 307,738 | Form 4 | |||
| LAV Biosciences Fund V, L.P. | 10% owner | Conversion | 307,738 | Form 4 | |||
| Zhu Rui (NMN) | Chief Technology Officer | Options or other derivatives | Form 4 | ||||
| Alan Robert MacLeod | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Ryan Fisk | CFO and CBO | Options or other derivatives | Form 4 | ||||
| Zhen Li | President and CEO | Options or other derivatives | Form 4 | ||||
| Robert William Ackles | Chief People Officer | Options or other derivatives | Form 4 | ||||
| Simeon George | Director | Became an insider (Form 3) | Form 3 | ||||
| SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| ORBIMED ADVISORS LLC | Director | Became an insider (Form 3) | Form 3 | ||||
| LAV Biosciences Fund V, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Ying Huang | Director | Became an insider (Form 3) | Form 3 | ||||
| Mary Tagliaferri | Director | Became an insider (Form 3) | Form 3 | ||||
| Robert William Ackles | Chief People Officer | Became an insider (Form 3) | Form 3 | ||||
| Erez Chimovits | Director | Became an insider (Form 3) | Form 3 | ||||
| Zhu Rui (NMN) | Chief Technology Officer | Became an insider (Form 3) | Form 3 | ||||
| Alan Robert MacLeod | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Ryan Fisk | CFO and CBO | Became an insider (Form 3) | Form 3 | ||||
| Carl L Gordon | Director | Became an insider (Form 3) | Form 3 | ||||
| Zhen Li | President and CEO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.